(Q53415229)
Statements
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial. (English)
Bruno S
Torrisi R
Costantini M
Baglietto L
Fontana V
Gatteschi B
Melioli G
Nicolo G
Curotto A
Malcangi B
Bruttini GP
Varaldo M
Bruzzi P
Decensi A
1 December 1999
76
2
311-321